These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7342761)

  • 21. Urinary lead excretion in uremic patients.
    Behringer D; Craswell P; Mohl C; Stoeppler M; Ritz E
    Nephron; 1986; 42(4):323-9. PubMed ID: 3083277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels.
    Baker EL; Landrigan PJ; Barbour AG; Cox DH; Folland DS; Ligo RN; Throckmorton J
    Br J Ind Med; 1979 Nov; 36(4):314-22. PubMed ID: 508643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tubular carcinoma; animal model: chemically induced renal tubular carcinoma in rats.
    Heatfield BM; Lipsky MM; Trump BF
    Am J Pathol; 1980 Jul; 100(1):317-20. PubMed ID: 7395967
    [No Abstract]   [Full Text] [Related]  

  • 24. [Selected work-related nephropathies].
    Wołyniec W; Renke M; Wójcik-Stasiak M; Renke J
    Med Pr; 2015; 66(4):583-93. PubMed ID: 26536975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and treatment of occupational lead nephropathy.
    Wedeen RP; Malik DK; Batuman V
    Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic occupational lead exposure: the potential effect on sexual function and reproductive ability in male workers.
    Cunningham M
    AAOHN J; 1986 Jun; 34(6):277-9. PubMed ID: 3636134
    [No Abstract]   [Full Text] [Related]  

  • 27. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead.
    Cárdenas A; Roels H; Bernard AM; Barbon R; Buchet JP; Lauwerys RR; Roselló J; Ramis I; Mutti A; Franchini I
    Br J Ind Med; 1993 Jan; 50(1):28-36. PubMed ID: 8431388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure to nephrotoxins can lead to renal damage.
    Polakoff PL
    Occup Health Saf; 1984 Mar; ():65-6, 75. PubMed ID: 6709259
    [No Abstract]   [Full Text] [Related]  

  • 29. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic nephropathy in saturnism. Comparative elimination of lead by classic chelating agents and peritoneal dialysis].
    Mirouze J; Mion C; Mathieu-Daude P; Monnier L; Selam JL
    Nouv Presse Med; 1975 May; 4(22):1642-4. PubMed ID: 1215179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Disorders of liver function in occupational chronic lead and mercury vapor poisoning].
    Kośmider S; Potocka Z
    Zentralbl Arbeitsmed; 1967 Jun; 17(6):170-4. PubMed ID: 5616271
    [No Abstract]   [Full Text] [Related]  

  • 32. Decision rule approach applied to estimate occupational lead exposure in a case-control study of kidney cancer.
    Callahan CL; Locke SJ; Dopart PJ; Stewart PA; Schwartz K; Ruterbusch JJ; Graubard BI; Rothman N; Hofmann JN; Purdue MP; Friesen MC
    Am J Ind Med; 2018 Nov; 61(11):901-910. PubMed ID: 30291640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of kidney function in lead poisoning using radioisotopes].
    Klimentová G; Buchancová J; Gáliková E; Lepej J
    Bratisl Lek Listy; 1982; 78(4):428-38. PubMed ID: 7172056
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nephrologic complications caused by lead poisoning].
    Rodríguez Jornet A; Tovar JL; Ferrer E; Piera L
    Med Clin (Barc); 1984 Jun; 83(4):164-6. PubMed ID: 6482567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kidney involvement in industrial exposure to lead and cadmium].
    Balkarov IM; Dupliankin SA; Eliseeva NA; Kondakhchan MA; Barashkov GK; Lebedeva MV; Kriachnevskaia LN
    Ter Arkh; 1995; 67(5):34-6. PubMed ID: 7638774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Secondary nephropathies in occupational health practice. I. Secondary nephropathies due to occupational exposure].
    Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińiska D
    Med Pr; 2006; 57(4):389-400. PubMed ID: 17133921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of environmental and occupational lead exposure.
    Loghman-Adham M
    Environ Health Perspect; 1997 Sep; 105(9):928-38. PubMed ID: 9300927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N; D'Amico G
    Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kidney damage caused by lead exposure: historical aspects].
    Arkhipov EV; Garipova RV; Strizhakov LA; Bobkova IN; Tairova N
    Ter Arkh; 2022 Aug; 94(6):777-780. PubMed ID: 36286857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe.
    Boffetta P; Fontana L; Stewart P; Zaridze D; Szeszenia-Dabrowska N; Janout V; Bencko V; Foretova L; Jinga V; Matveev V; Kollarova H; Ferro G; Chow WH; Rothman N; van Bemmel D; Karami S; Brennan P; Moore LE
    Occup Environ Med; 2011 Oct; 68(10):723-8. PubMed ID: 21217163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.